In 2008 Chuck McCoy founded the North Texas Angel Network, a group that today includes 60 entrepreneurs investing in promising early stage companies. Chuck has had 25 years’ experience in the software business, initially with Arthur Andersen and subsequently as an independent product developer for large companies such as AT&T, E-Systems and MCI. With an accounting background and extensive sales experience, he has helped multiple businesses grow through M&A as well as new product roll out. He has served as Director of Commercialization Programs at the North Texas RCIC and helped the Texas Emerging Technology Fund become an important funding source for technology start-ups. He holds a BBA from Oklahoma City University, an MS (Economics) from Oklahoma State University, and is a veteran of the US Army (A Battery, 6th Battalion, 33rd Field Artillery, 1968).
Chairman of the Board
Jim Lafferty is currently Chairman, CEO and Founder of Genesis Biosystems, a medical device company servicing the plastic surgery, dermatology and aesthetic medicine markets. Jim also co-founded Osteomed Corporation, a manufacturer of small bone reconstruction implants and electro-mechanical instrumentation used in the operating room by numerous surgical specialties, including plastic, ENT, neuro, oral & maxillofacial, orthopedic and podiatric surgery. In 1999, Osteomed was sold to the Marmon Group owned by the Pritzker family of Chicago and is now owned personally by Mr. Robert Pritzker. Mr. Lafferty is a graduate of Gannon University, where he received his Bachelor of Science degree in Mechanical Engineering in 1982. He also pursued graduate business studies at the University of Southern California from 1988-1989 and holds four U.S. patents.
Immediate Past Chairman
Fred Marxer’s passion for business has enabled him to be an angel investor, serial entrepreneur, big company executive, and college professor. Driven by his belief that entrepreneurs and their early stage companies are the heart and future of America, Fred has screened hundreds of startups, worked on over 30 due diligence teams and invested in 14 companies serving several as a board member. He is currently Chairman of the Board of the North Texas Angel Network and is NTAN’s representative to the Alliance of Texas Angel Networks.
Mike Bartlett is President of Vital Art and Science Incorporated (VAS), an early stage medical equipment start-up company developing home-based vision function testing for tracking of degenerative diseases of the eye, including Age-related Macular Degeneration (AMD) and diabetic retinopathy. VAS has won NIH/National Eye Institute SBIR Phase I and Phase II Grants as well as funding from the Texas Emerging Technology Fund (ETF). VAS is currently collaborating with a multinational Drug company to validate its first product. In addition to being an active angel investor, Mike is a founding member of NTAN and served for several years as Chairman. He is currently a director for several early stage companies. Previously Mike spent a 28 year career with Texas Instruments, Inc. (TI) in Dallas, TX eventually serving for 5 years as Vice President – High Speed Communications Products.